News

Patients taking Kerendia saw significant reduction in cardiovascular death and hospitalization and urgent visits for heart ...
A cardiologist spotlights cardiac amyloidosis, a protein disease often mistaken for hypertension. Learn the signs and how to get screened.
The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.
Heart failure, a leading cause of death in the US, can be triggered by cardiac amyloidosis, a condition often misdiagnosed as ...
Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...
The US regulator has cleared use of Kerendia (finerenone) for the treatment of heart failure patients who have a left ...
The use of SGLT2 inhibitors has been a game-changer in the treatment of heart failure (HF). Now, another drug class has ...
Heart failure, a condition where the heart doesn't pump blood efficiently, manifests through symptoms like shortness of ...
Wearables and telehealth are teaming up to transform chronic care. This connected model offers real-time data for proactive, ...
Micah Clayborne was diagnosed with Danon disease, a rare condition, after complaining of chest pains. He needed a heart ...
Warning signs of an unhealthy heart, though, can lurk — not so quietly — in its many complex sounds. That's why FIU researchers Joshua Hutcheson and Valentina Dargam have come up with a way to "listen ...
Discover how MemorialCare's Women's Heart Center at Long Beach is tackling the leading killer of women, heart disease, ...